Applied Genetic Technologies (AGTC)

Applied Genetic Technologies (AGTC) Financial Statements


Applied Genetic Technologies Financial Overview

Applied Genetic Technologies's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Applied Genetic Technologies is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 0.00$ 325.00K$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -17.68M$ -17.65M$ -13.57M$ -18.44M$ -16.42M
EBITDA$ -17.31M$ -17.26M$ -13.20M$ -18.05M$ -16.05M
Net Income Common Stockholders$ -18.41M$ -18.39M$ -14.29M$ -19.14M$ -17.12M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 34.24M$ 46.37M$ 67.85M$ 72.77M$ 90.52M
Total Assets$ 57.33M$ 66.68M$ 87.19M$ 92.37M$ 110.41M
Total Debt$ 20.15M$ 22.47M$ 24.56M$ 24.63M$ 24.44M
Net Debt$ -14.09M$ -23.89M$ -43.29M$ -48.15M$ -66.07M
Total Liabilities$ 39.69M$ 37.21M$ 40.16M$ 40.88M$ 40.89M
Stockholders Equity$ 17.65M$ 29.48M$ 47.03M$ 51.49M$ 69.53M
Cash Flow-
Free Cash Flow$ -16.34M$ -19.12M$ -14.20M$ -17.89M$ -16.55M
Operating Cash Flow$ -16.04M$ -18.26M$ -14.00M$ -17.56M$ -15.94M
Investing Cash Flow$ -304.00K$ -860.00K$ -202.00K$ -337.00K$ 1.39M
Financing Cash Flow$ 7.14M$ -2.37M$ 9.28M$ 150.00K$ 14.00K
Currency in USD

Applied Genetic Technologies Earnings and Revenue History

Applied Genetic Technologies Debt to Assets

Applied Genetic Technologies Cash Flow

Applied Genetic Technologies Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis